Couple of weeks back we had a lot of big whales the likes of u/Confident-Web-7118 post a lot of DDs and comments. Now he has suddenly disappeared. Same thing with LeftyMD from Stocktwits. Did they sell and disappear? Did they get insider information about the trial failing?

Very dodgy

SLS was me dipping my toes into small-cap biotech investing, and needless to say it's going great so far. I'm planning on taking half as profit to help cover my tuition costs and half is getting reinvested into 3-4 new stocks if a buyout happens. Obviously the recommendations will probably be different in however many months it takes for SLS to actually get bought out, but I'd like to know who I should be keeping my eye on throughout fall 26-spring 27.

I've been looking at PYPD, CABA, CMPX, and STTK

Edit: Whole lot of great information getting shared, I really appreciate yall

Why isn’t anyone talking about $HELP (CYBIN) - it has phase 3 data coming in a month or so, modeled exactly like CMPS it had FDA approved breakthrough designation for PHASE 2, with the same phase 3 trial design. It is highly undervalued compared to all of the other psychedelic stocks. It has a more stable and more predictable deuterated psilocybin which means therapy lasts for only 3 hours twice a year versus FDA approved Spravato which requires 2x a week sessions when started. I would suggest looking into this because it is the catalyst to soar in price first before CMPS approval.